Augmentation of myocardial I<sub>f</sub> dysregulates calcium homeostasis and causes adverse cardiac remodeling.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31337768.
- Also identified by DOI 10.1038/s41467-019-11261-2 and PMC identifier 6650438.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
HCN channels underlie the depolarizing funny current (I<sub>f</sub>) that contributes importantly to cardiac pacemaking. I<sub>f</sub> is upregulated in failing and infarcted hearts, but its implication in disease mechanisms remained unresolved. We generated transgenic mice (HCN4<sup>tg/wt</sup>) to assess functional consequences of HCN4 overexpression-mediated I<sub>f</sub> increase in cardiomyocytes to levels observed in human heart failure. HCN4<sup>tg/wt</sup> animals exhibit a dilated cardiomyopathy phenotype with increased cellular arrhythmogenicity but unchanged heart rate and conduction parameters. I<sub>f</sub> augmentation induces a diastolic Na<sup>+</sup> influx shifting the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger equilibrium towards 'reverse mode' leading to increased [Ca<sup>2+</sup>]<sub>i</sub>. Changed Ca<sup>2+</sup> homeostasis results in significantly higher systolic [Ca<sup>2+</sup>]<sub>i</sub> transients and stimulates apoptosis. Pharmacological inhibition of I<sub>f</sub> prevents the rise of [Ca<sup>2+</sup>]<sub>i</sub> and protects from ventricular remodeling. Here we report that augmented myocardial I<sub>f</sub> alters intracellular Ca<sup>2+</sup> homeostasis leading to structural cardiac changes and increased arrhythmogenicity. Inhibition of myocardial I<sub>f</sub> per se may constitute a therapeutic mechanism to prevent cardiomyopathy.
Medical subject headings
- Calcium
- Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
- Muscle Proteins
- Potassium Channels